Aikido Pharma has developed a new compound for the
Aikido Pharma has developed a new compound for the treatment of pancreatic cancer. DHA-dFdc is a new compound that holds promising indications of becoming the next generation of chemotherapy treatment for advanced pancreatic cancer. Get in touch with us today for more information by calling 212-745-1373.
-
Meet Aikido Pharma A BioTechnology Development Company Focused on The Treatment Of Early and Mid-Stage Small-Molecule Anti-Cancer Therapeutics